Concepedia

Endpoint Sensitivity Analysis

Endpoint Sensitivity Analysis is a methodological framework in drug efficacy assessment that evaluates the robustness of clinical trial outcomes by systematically varying the definitions or measurement criteria of primary and secondary endpoints to determine the extent to which conclusions about treatment effectiveness are influenced by such variations.

12

Publications

789

Citations

67

Authors

39

Institutions

Publications per year

2017–2026

4

Parents

Publications

12

Imipramine and Chlordiazepoxide in Depressive and Anxiety Disorders

R. Kahn · Archives of General Psychiatry · 1986 · 279 citations

, , +16

Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial

Michael Untch, Richard D. Gelber, Christian Jackisch et al. · Annals of Oncology · 2008 · 197 citations

, , +13

Treatment effect quantification for time‐to‐event endpoints–Estimands, analysis strategies, and beyond

Pharmaceutical Statistics · 2018 · 61 citations · Full text

, , +14

Imipramine and Chlordiazepoxide in Depressive and Anxiety Disorders

Ronald S. Lipman · Archives of General Psychiatry · 1986 · 46 citations

, , +16

Endpoint sensitivity in fish endocrine disruption assays: Regulatory implications

ZhiChao Dang, Kang Li, Haowen Yin et al. · Toxicology Letters · 2011 · 39 citations

, , +15

1–5 of 12

Authors

67

  1. ZD
    ZhiChao Dang

    National Institute for Public Health and the Environment, Netherlands

    2 publications · 71 citations

    2

    h-index

  2. DJ
    Daniel J. Sargent

    Mayo Clinic, United States

    1 publications · 38 citations

    1

    h-index

  3. RB
    R. Bell

    Roche (Switzerland), Switzerland

    1 publications · 197 citations

    1

    h-index

  4. TS
    T. Suarez Sahui

    Breast International Group, Belgium

    1 publications · 197 citations

    1

    h-index

  5. BL
    Brian Leyland‐Jones

    Avera Health, United States

    1 publications · 197 citations

    1

    h-index

1–5 of 67

Institutions

39

  1. Dana-Farber Cancer Institute

    Boston, United States

    2 h-index

    5 publications

    349 citations

  2. National Institute for Public Health and the Environment

    De Bilt, The Netherlands

    2 h-index

    4 publications

    149 citations

  3. Roche (Switzerland)

    Basel, Switzerland

    2 h-index

    2 publications

    258 citations

  4. Vall d'Hebron Hospital Universitari

    Barcelona, Spain

    1 h-index

    1 publications

    197 citations

  5. Helios Hospital Berlin-Buch

    Berlin, Germany

    1 h-index

    1 publications

    197 citations

  6. Royal Marsden NHS Foundation Trust

    London, United Kingdom

    1 h-index

    1 publications

    197 citations

  7. Université Libre de Bruxelles

    Brussels, Belgium

    1 h-index

    2 publications

    394 citations

  8. Chinese Academy of Medical Sciences & Peking Union Medical College

    Beijing, China

    1 h-index

    1 publications

    197 citations

1–8 of 39

Venues

  1. Regulatory Toxicology and Pharmacology

    RTP · 2 publications · 51 citations

    2

    h-index

  2. Archives of General Psychiatry

    2 publications · 325 citations

    2

    h-index

  3. Pharmaceutical Statistics

    1 publications · 61 citations

    1

    h-index

  4. Environmental Pollution

    1 publications · 12 citations

    1

    h-index

  5. Ecotoxicology and Environmental Safety

    EES · 1 publications · 32 citations

    1

    h-index

1–5